Five innovative projects across Northern Ireland and Wales have been awarded a share of £1million to develop technology to reduce waiting times and improve outcomes for cancer patients.

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.Vitamin C also ...

Abu Dhabi-based global healthcare giant M42 is at the forefront of transforming healthcare delivery by leveraging ...

Cancer is a leading cause of mortality worldwide, and men above 40 are particularly at risk for certain types. While several ...

Medicare beneficiaries with emphysema who received an endobronchial valve vs. lung volume reduction surgery faced elevated ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.